80 FR 46286 - Proposed Information Collection Activity; Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families

Federal Register Volume 80, Issue 149 (August 4, 2015)

Page Range		46286-46287
FR Document		2015-18987

Federal Register, Volume 80 Issue 149 (Tuesday, August 4, 2015)

[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Pages 46286-46287]
From the Federal Register Online [www.thefederalregister.org]
[FR Doc No: 2015-18987]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Children and Families

Proposed Information Collection Activity; Comment Request

Proposed Projects

Title: 45 CFR 303.7--Provision of Services in Intergovernmental IV-
D; Federally Approved Forms.
OMB No.: 0970-0085.
Description: Public Law 104-193, the Personal Responsibility and
Work Opportunity Reconciliation Act of 1996, amended 42 U.S.C. 666 to
require State Child Support Enforcement (CSE) agencies to enact the
Uniform Interstate Family Support Act (UIFSA) into State law by January
1, 1998. Section 311(b) of UIFSA requires the States to use forms
mandated by Federal law. 45 CFR 303.7 also requires child support
programs to use federally-approved forms in intergovernmental IV-D
cases unless a country has provided alternative forms as a part of its
chapter in a Caseworker's Guide to Processing Cases with Foreign
Reciprocating Countries.
Respondents: State agencies administering a child support program
under title IV-D of the Social Security Act.

Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Transmittal #1--Initial Request..... 54 19,440 0.17 178,459.20
Transmittal #1--Initial Request 54 19,440 0.05 52,488.00
Acknowledgement *..................
Transmittal #2--Subsequent Action... 54 14,580 0.08 62,985.60
Transmittal #3--Request for 54 2,700 0.08 11,664.00
Assistance/Discovery...............
Uniform Support Petition............ 54 6,480 0.05 17,496.00
General Testimony................... 54 6,480 0.33 115,473.60
Declaration in Support of 54 2,700 0.15 21,870.00
Establishing Parentage.............
Locate Data Sheet................... 54 388 0.05 1,047.60
Notice of Determination of 54 54 0.25 729.00
Controlling Order..................
Letter of Transmittal Requesting 54 14,310 0.08 61,819.20
Registration.......................
Personal Identifiable Information 54 37,584 0.05 101,476.80
(PII) Form *.......................
Request for Change of Support 54 27,000 0.05 72,900.00
Payment Location Pursuant to UIFSA
319(b) *...........................
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: ................. ................. ................. 698,409.00
----------------------------------------------------------------------------------------------------------------
*--New Forms

[[Page 46287]]

In compliance with the requirements of Section 506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Planning, Research and Evaluation, 370 L'Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF Reports Clearance Officer. Email
address: infocollection@acf.hhs.gov. All requests should be identified
by the title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden information to be
collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.

Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2015-18987 Filed 8-3-15; 8:45 am]
BILLING CODE 4184-01-P

Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices 46287

In compliance with the requirements DEPARTMENT OF HEALTH AND after this document publishes in the
of Section 506(c)(2)(A) of the Paperwork HUMAN SERVICES Federal Register).
Reduction Act of 1995, the
Administration for Children and Food and Drug Administration FOR FURTHER INFORMATION CONTACT: Ann
Families is soliciting public comment Anonsen, University of Maryland,
on the specific aspects of the Fischell Dept. of Bioengineering, 2207
[Docket No. FDA–2015–N–2390]
information collection described above. Jeong H. Kim Bldg., College Park, MD
Copies of the proposed collection of Evidentiary Considerations for 20742, 301–405–0285, FAX: 304–405–
information can be obtained and Integration of Biomarkers in Drug 9953, aanonsen@umd.edu.
comments may be forwarded by writing Development; Notice of Public SUPPLEMENTARY INFORMATION:
to the Administration for Children and Meeting; Request for Comments
Families, Office of Planning, Research I. Background
and Evaluation, 370 L’Enfant AGENCY: Food and Drug Administration,
Promenade, SW., Washington, DC HHS. The purpose of this public workshop
20447, Attn: ACF Reports Clearance ACTION: Notice of public meeting; is to facilitate a unique opportunity for
Officer. Email address: infocollection@ request for comments. relevant stakeholders from industry,
acf.hhs.gov. All requests should be academia, and FDA to discuss
identified by the title of the information SUMMARY: The Food and Drug biomarker development and provide a
collection. Administration (FDA), in collaboration framework for evidentiary
The Department specifically requests with the University of Maryland’s considerations required for biomarker
comments on: (a) Whether the proposed Center of Excellence in Regulatory qualification. The objective of the
collection of information is necessary Science and Innovation and the Critical workshop is to discuss evidentiary
for the proper performance of the Path Institute, is announcing a public considerations for use of clinical safety
functions of the agency, including workshop entitled ‘‘Evidentiary and enrichment biomarkers in drug
whether the information shall have Considerations for Integration of development.
practical utility; (b) the accuracy of the Biomarkers in Drug Development.’’ The
agency’s estimate of the burden of the purpose of the meeting is to discuss A. Registration
proposed collection of information; (c) current scientific approaches to
the quality, utility, and clarity of the biomarker development, acceptance, There is a registration fee to attend
information to be collected; and (d) and utility in drug and biologic this meeting. The registration fee is
ways to minimize the burden (hereafter referred to as therapeutic charged to help defray the costs for
information to be collected; and (d) product) development programs. facilities, materials, and food. Seats are
ways to minimize the burden of the limited, and registration will be on a
DATES: The meeting will be held on
collection of information on first-come, first-served basis.
August 21, 2015, from 9 a.m. to 5 p.m.
respondents, including through the use To register, please complete
of automated collection techniques or ADDRESSES: The meeting will be held at
the University of Maryland, Pharmacy registration online at http://
other forms of information technology. www.pharmacy.umaryland.edu/cersibio
Consideration will be given to Hall, 20 North Pine St., Baltimore, MD
21201. For additional travel and hotel markers. (FDA has verified the Web
comments and suggestions submitted address, but FDA is not responsible for
within 60 days of this publication. information, please refer to
www.pharmacy.umaryland.edu/ subsequent changes to the Web site after
Robert Sargis, cersibiomarkers. (FDA has verified the this document publishes in the Federal
Reports Clearance Officer. Web site addresses throughout this Register). The costs of registration for
[FR Doc. 2015–18987 Filed 8–3–15; 8:45 am] notice, but FDA is not responsible for the different categories of attendees are
BILLING CODE 4184–01–P subsequent changes to the Web sites as follows:

Category Cost

Industry Representatives ............................................................................................................................................................. $50
Charitable Nonprofit/Academic .................................................................................................................................................... 50
Government ................................................................................................................................................................................. 0

B. Accommodations Identify all comments with the DEPARTMENT OF HEALTH AND
Attendees are responsible for their corresponding docket number found in HUMAN SERVICES
own hotel accommodations. If you need brackets in the heading of this
special accommodations due to a document. Received comments may be Indian Health Service
disability, please contact Ann Anonsen seen in the Division of Dockets [Funding Announcement Number: HHS–
(see FOR FURTHER INFORMATION CONTACT). Management between 9 a.m. and 4 p.m., 2016–IHS–SDPI–0001; Catalog of Federal
Monday through Friday, and will be Domestic Assistance Number: 93.237]
II. Comments posted to the docket at http://
Interested persons may submit www.regulations.gov. Special Diabetes Program for Indians;
tkelley on DSK3SPTVN1PROD with NOTICES

electronic comments to http:// Community-Directed Grant Program;
Dated: July 29, 2015.
www.regulations.gov or written Announcement Type: New and
comments to the Division of Dockets Leslie Kux, Competing Continuation
Management (HFA–305), Food and Drug Associate Commissioner for Policy.
Administration, 5630 Fishers Lane, Rm. [FR Doc. 2015–19037 Filed 8–3–15; 8:45 am]
Key Dates
1061, Rockville, MD 20852. It is only BILLING CODE 4164–01–P Application Deadline Date: October 7,
necessary to send one set of comments. 2015.

VerDate Sep<11>2014 18:45 Aug 03, 2015 Jkt 235001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\04AUN1.SGM 04AUN1

Document Created: 2015-12-18 14:51:43
Document Modified: 2015-12-18 14:51:43

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		80 FR 46286

80 FR 46286 - Proposed Information Collection Activity; Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICESAdministration for Children and Families

Federal Register Volume 80, Issue 149 (August 4, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families